Latest Property Portfolio News

Autosports Group Limited reports record FY25 revenue and profit, while announcing a strategic acquisition of 10 Barry Bourke Motors dealerships in Victoria, signaling robust growth momentum into FY26.

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Charter Hall Group reported solid FY25 financial results with significant earnings growth and sustainability milestones, while guiding higher earnings and distributions for FY26.

CVC Limited has released a replacement prospectus for its $75 million CVC Notes 3 offer, combining a New Money Offer and a Reinvestment Offer for existing CVCHA holders. The notes aim to support CVC’s capital management and real estate investment strategy.

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.

Desane Group Holdings posted a $3.3 million net profit for FY25, bolstered by key lease extensions and a $6.2 million property valuation uplift despite ongoing post-pandemic challenges.

Archer Materials has partnered with CSIRO to develop cutting-edge quantum machine learning models aimed at revolutionizing fraud detection in financial transactions.

The GPT Group has reported robust occupancy and sales growth across its property portfolios for the September quarter 2025, prompting an upgrade to its full-year earnings guidance.

Vicinity Centres delivered a robust FY25 with statutory net profit surpassing $1 billion, driven by strategic premium asset acquisitions and successful retail developments. The company reaffirms its positive earnings guidance for FY26 amid sustained retail sales growth and high occupancy.

Growthpoint Properties Australia kicks off FY26 with robust leasing activity, high occupancy rates, and a strategic $24 million industrial acquisition, maintaining its financial guidance and sustainability credentials.

Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.

Goodman Group reports robust progress in Q1 FY26 with a $12.4 billion development pipeline dominated by data centres, reaffirming a 9% operating EPS growth forecast. The group is advancing logistics automation and expanding data centre capacity across key global markets.